Insulin resistance, common in type 2 diabetes, is associated with elevated insulin levels and can create an unfavorable tumor microenvironment characterized by increased inflammation and impaired immune response, facilitating tumor growth and treatment resistance [11, 70]. This evidence concerns the gene INS and neoplasm.